| Protocols | ||
|---|---|---|
| 3 protocol(s) meet the specified criteria | ||
| Drug: INTERFERON ALFA-2B | ||
| Protocol No. | Title | Status |
| ECOG1609-CIRB | A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Vs High Dose Interferon alpha2b for Resected High-Risk Melanoma | Open (affiliates only) |
| GO29322 | A Phase Ib Study of the Safety and Pharmacology of Atezolizumab (Anti-PD-L1 Antibody) Administered with Ipilimumab, Interferon-Alpha, or Other Immune-Modulating Therapies in Patients with Locally Advanced or Metastatic Solid Tumors | Open |
| S1404-CIRB-MK-3475-053 | S1404: A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients with High Risk Resected Melanoma | Open |